S Ravi Kumar, CEO of the US-based software program firm with a big worker base in India, mentioned within the March quarter alone, seven new AI patents had been accredited and granted to the corporate. “In quarter one, we introduced a collection of latest partnerships and co-innovations behind the technique we introduced final 12 months to speculate $1 billion in generative AI over three years. This consists of our collaboration with Microsoft to infuse GenAI into healthcare administration,” he advised analysts whereas discussing the primary quarter monetary outcomes.
- Learn: Cognizant studies 6% drop in Q1 internet revenue, income declines to $4.8 billion
A US-based Grand View Analysis report says that the worldwide AI market dimension was estimated at $197 billion in 2023 and is projected to develop at a CAGR of 36.6 per cent from 2024 to 2030. The continual analysis and innovation directed by tech giants drive the adoption of superior applied sciences in business verticals, similar to automotive, healthcare, retail, finance, and manufacturing. For example, in December 2023, Google LLC launched ‘Gemini’, a big language AI mannequin made obtainable in three sizes, particularly, Gemini Nano, Gemini Professional, and Gemini Extremely. Gemini stands out from its rivals as a result of its native multimodal traits.
AI demand
Cognizant’s Kumar mentioned there may be elevated demand for AI providers throughout 4 key areas. First, buyer and worker expertise as shoppers search to ship improved interactions by way of hyper-personalisation. Second, content material summarisation insights to empower decision-making. Third is about content material era and, lastly, leveraging GenAI to speed up innovation and know-how growth cycles, he mentioned.
- Learn: Cognizant to pay hikes to eligible workers in August: CEO
“We proceed to see robust curiosity from shoppers as they assess proofs of idea and the return on funding of those alternatives. These efforts are supported by a not too long ago launched superior synthetic intelligence lab in San Francisco the place we’re investing as an alternative of the artwork core AI analysis, aiming to place us on the forefront of innovation in our business. This builds upon our community of AI innovation studios in London, New York, San Francisco, Dallas and Bangalore,” he mentioned.
Scientific analysis AI
By leveraging GenAI-infused fashions, scientific researchers can quickly sift by way of intensive datasets, extra precisely predict interactions between drug compounds and create new viable drug growth pathways.
Cognizant additionally expanded its partnership with Google Cloud. Cognizant will undertake Gemini – a multimodal AI mannequin that may purpose throughout textual content, pictures, audio, video, and code – for Google Cloud in two methods. First, it should practice Cognizant associates to make use of Gemini for software program growth help, and second, it should combine Gemini’s superior capabilities inside Cognizant’s inner operations and platforms.
Utilizing Gemini for Google Cloud, Cognizant’s builders can be outfitted to put in writing, check, and deploy code sooner and extra successfully with the assistance of AI-powered instruments, bettering the reliability and value effectivity of constructing and managing consumer functions.
Over the following 12 months, Cognizant expects to upscale greater than 70,000 cross-functional associates on Google Cloud’s AI choices. That is one other milestone in our Synapse initiative to upscale 1 million people globally by 2026, he mentioned.
#Cognizants #superior #lab #produces #patents #counting